| Structural insights into the role of the Smoothened cysteine-rich domain in Hedgehog signalling R Rana, CE Carroll, HJ Lee, J Bao, S Marada, CRR Grace, CD Guibao, ... Nature communications 4 (1), 2965, 2013 | 88 | 2013 |
| Targeting liver fibrosis with a cell-penetrating protease-activated receptor-2 (PAR2) pepducin AM Shearer, R Rana, K Austin, JD Baleja, N Nguyen, A Bohm, L Covic, ... Journal of Biological Chemistry 291 (44), 23188-23198, 2016 | 67 | 2016 |
| Noncanonical matrix metalloprotease 1–protease-activated receptor 1 signaling drives progression of atherosclerosis R Rana, T Huang, G Koukos, EK Fletcher, SE Turner, A Shearer, ... Arteriosclerosis, thrombosis, and vascular biology 38 (6), 1368-1380, 2018 | 49 | 2018 |
| Allosteric activation of a G protein-coupled receptor with cell-penetrating receptor mimetics P Zhang, AJ Leger, JD Baleja, R Rana, T Corlin, N Nguyen, G Koukos, ... Journal of Biological Chemistry 290 (25), 15785-15798, 2015 | 46 | 2015 |
| PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease R Rana, AM Shearer, EK Fletcher, N Nguyen, S Guha, DH Cox, ... Molecular Metabolism 29, 99-113, 2019 | 34 | 2019 |
| PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference AM Shearer, Y Wang, EK Fletcher, R Rana, ES Michael, N Nguyen, ... Hepatology 76 (6), 1778-1793, 2022 | 25 | 2022 |
| Tackling AKI R Rana, MD Breyer Journal of the American Society of Nephrology 34 (6), 935-936, 2023 | 1 | 2023 |
| VEPTP inhibition with an extracellular domain targeting antibody did not restore albuminuria in a mouse model of diabetic kidney disease R Rana, TA Natoli, P Khandelwal, P Pissios, AB Muhammad, ... Physiological Reports 12 (18), e70058, 2024 | | 2024 |
| Integrin α3β1 as a Potential Target for Diabetic Kidney Disease (DKD): SA-PO1006 NO Bukanov, TA Natoli, V Chipashvili, W Zhou, R Rana, P Pissios, ... Journal of the American Society of Nephrology 34 (11S), 1011, 2023 | | 2023 |
| Effect of Genetic Deficiency of Matrix Metalloprotease 1a in ApoE-/-Mouse Models of Atherosclerosis E Fletcher, R Rana, S Turner, L Covic, A Kuliopulos Circulation 138 (Suppl_1), A15942-A15942, 2018 | | 2018 |
| Metabolomic analyses reveal a novel role for Protease Activated Receptor-2 (PAR2) in driving steatosis in Non-Alcoholic Steatohepatitis (NASH) R Rana, AM Shearer, C Calnan, N Nguyen, L Fynn, T Huang, J Baleja, ... HEPATOLOGY 63 (1 SUPP), 568A-568A, 2016 | | 2016 |
| Protease-Activated Receptor-2 (PAR2) Reduces Lipid-Catabolism and Promotes the Development of Hepatic Steatosis in High Fat Diet AM Shearer, R Rana, S Guha, N Nguyen, J Baleja, L Covic, A Kuliopulos HEPATOLOGY 63 (1 SUPP), 70A-71A, 2016 | | 2016 |
| Structural Insights Into the Role of the Smoothened Cysteine Rich Domain in Hedgehog Signalling R Rana, C Carroll, HJ Lee, J Bao, S Marada, G Royappa, S Ogden, ... PROTEIN SCIENCE 23, 83-83, 2014 | | 2014 |
| Novel insights into the role of the smoothened cysteine rich domain in Hedgehog signalling R Rana The University of Tennessee Health Science Center, 2014 | | 2014 |
| DNA damage in exfoliated buccal cells and antioxidant status of saliva in brain tumour patients RP Shenoy, A Vatsa, S Sahoo, R Rana, G Nayak, P Bhat, G Kalthur, ... 海南医学院学报 10, 2010 | | 2010 |
| Full wwPDB NMR Structure Validation Report i○ KH Lee, DG Lee, YK Park, KS Harm | | |
